ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $286,979 | -33.8% | 142,069 | -3.3% | 0.00% | -100.0% |
Q2 2023 | $433,559 | +26.4% | 146,969 | +7.1% | 0.00% | 0.0% |
Q1 2023 | $342,923 | -26.1% | 137,169 | -6.4% | 0.00% | 0.0% |
Q4 2022 | $464,061 | +14.9% | 146,569 | +7.8% | 0.00% | 0.0% |
Q3 2022 | $404,000 | -1.9% | 136,019 | +0.7% | 0.00% | 0.0% |
Q2 2022 | $412,000 | -77.3% | 135,019 | +0.4% | 0.00% | -75.0% |
Q1 2022 | $1,817,000 | +3.2% | 134,519 | -0.4% | 0.00% | +33.3% |
Q4 2021 | $1,761,000 | +43.5% | 135,119 | +3.2% | 0.00% | 0.0% |
Q3 2021 | $1,227,000 | -8.5% | 130,894 | -0.1% | 0.00% | 0.0% |
Q2 2021 | $1,341,000 | +380.6% | 130,994 | +762.9% | 0.00% | +200.0% |
Q1 2021 | $279,000 | -43.4% | 15,180 | +5.6% | 0.00% | 0.0% |
Q4 2020 | $493,000 | +24550.0% | 14,380 | +14280.0% | 0.00% | – |
Q3 2020 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
Logos Global Management LP | 220,000 | $671,000 | 0.12% |
PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
SG3 Management, LLC | 206,000 | $628,000 | 0.07% |